Medical devices, healthcare technology and the business of care
510(k) clearance · K262478

BCS Bioceramic Sealer

BCS Device Pte., Ltd. · Decision date Oct 16, 2026

MEDTECHLEDGER EXPLANATIONK262478

What did the FDA decide?

The FDA's 510(k) record K262478 covers the BCS Bioceramic Sealer, submitted by BCS Device Pte., Ltd. of Singapore. The device falls under product code KIF, classified as a resin for root canal filling, with Dental as the regulation medical specialty and review panel. The application was a traditional 510(k) received on 07/20/2026 and was not reviewed by a third party.

On 10/16/2026, FDA recorded a decision of Substantially Equivalent (SESE) for K262478. That decision is a 510(k) clearance, not a premarket approval. The record does not include a predicate device, a summary of the technological comparison, or the indications for use, so the specific component or changed item assessed and the basis for the equivalence finding remain unknown from this page. No combination product or authorized predetermined change control plan is recorded.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Dental
Decision date
Oct 16, 2026
FDA decision documents: 510(k) Premarket Notification

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262478
Regulatory pathway
510(k) premarket notification
Product code
KIF
Decision code
SESE
Decision date
Oct 16, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Resin, Root Canal Filling.

Product code
KIF
FDA device class
2

FDA decision timeline

  1. K262478 received

    Application receipt date recorded by FDA.

  2. K262478 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code KIF

Product / regulatory recordCompanyPathwayDecision dateSource
Vioseal XK262050
Spident Co., Ltd.510(k) clearanceSep 11, 2026FDA
NuSmile, Ltd.510(k) clearanceSep 4, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

BCS Device Pte., Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Singapore

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records